| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2769 | 2020 |
| Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre … APS Munro, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, M Bula, ... The Lancet 398 (10318), 2258-2276, 2021 | 670 | 2021 |
| Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a … APS Munro, S Feng, L Janani, V Cornelius, PK Aley, G Babbage, D Baxter, ... The Lancet Infectious Diseases 22 (8), 1131-1141, 2022 | 137 | 2022 |
| Risk factors for persistent abnormality on chest radiographs at 12-weeks post hospitalisation with PCR confirmed COVID-19 TJM Wallis, E Heiden, J Horno, B Welham, H Burke, A Freeman, L Dexter, ... Respiratory research 22 (1), 157, 2021 | 29 | 2021 |
| Predicting the risk of chest radiograph abnormality 12-weeks post hospitalisation with SARS CoV-2 PCR confirmed COVID-19 TJM Wallis, B Welham, A Kong, T Morelli, A Azim, J Horno, M Wilkinson, ... Respiratory Research 23 (1), 297, 2022 | 2 | 2022 |
| S108 Biological predictors of severity in respiratory viral infection (RVI): preliminary data from UNIVERSAL, a multicentre prospective observational study T Morelli, M Purcell, A Kong, B Welham, C Roberts, A Allen, N Scott, ... Thorax 78 (Suppl 4), A77-A78, 2023 | | 2023 |
| Alpha-Antitrypsin Deficiency as a cystic lung disease A Fazleen, A Abbas, J Dunbar, B Welham, A Kong, T Wilkinson European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Bioradiomic SPECT-CT quantification of active lung inflammation is influenced by heterogeneity of lung tissue B Welham, M Bennett, K Ostridge, M Guy, C Zvavamwe, F Sundram, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Towards precision medicine in COPD: Bioradiomic SPECT-CT quantification of active lung inflammation B Welham, M Bennett, K Ostridge, M Guy, C Zvavamwe, F Sundram, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Health inequality and COPD A Fazleen, A Freeman, A Kong, T Morelli, A Watson, B Welham, ... Inequalities in Respiratory Health, 129, 2023 | | 2023 |
| A review of patients following a diagnosis of unclassified interstitial lung disease (ILD) at a tertiary centre F Thompson, T Wallis, K Pontoppidan, C Brereton, E Reid, B Welham, ... European Respiratory Journal 56 (suppl 64), 2020 | | 2020 |
| P57 Peripheral blood monocyte count as a prognostic marker in fibrotic interstitial lung disease (fILD): analysis from a single UK specialist centre TJM Wallis, K Pontoppidan, CJ Brereton, B Welham, MG Jones, ... Thorax 74 (Suppl 2), A120, 2019 | | 2019 |
